Archives

by in
Entry Author Date Location
AAVLife Gets $12M to Bring Gene Therapy to Rare Ataxia 04/15/14 Boston
East Coast Biotech Roundup: Neurophage, Boston Biotech, Insmed, & More 03/28/14 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Third Rock’s Voyager Hunts For CNS Disorders With Gene Therapy 02/12/14 Boston
Gene Therapy Lurches Ahead, Sees Thorny Future Questions on Price 01/27/14 National
Celgene Plunks Down $177M Upfront for OncoMed’s Stem Cell Drugs 12/03/13 San Francisco
Dimension, Backed by Fidelity, Targets Hemophilia With Gene Therapy 10/31/13 Boston
Sage Therapeutics Nabs $20M Series B From Third Rock, Arch 10/16/13 Boston
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech 10/16/13 Boston
East Coast Life Sciences Roundup: Verdine, Ariad, Karyopharm, & More 10/11/13 Boston
Boston’s Life Science Disruptors: The Photos 10/07/13 Boston
9 Takeaways from Boston’s Life Science Disruptors 10/04/13 Boston
East Coast Life Sciences Roundup: Foundation, Ophthotech, Sato, & More 09/27/13 Boston
Foundation Medicine Scores $106M in Upsized IPO 09/24/13 Boston
Bluebird, Moderna, Genocea to Share Their Stories on Oct. 2 09/12/13 Boston
Biotech and Fantasy Football Picks for Fall 2013 09/03/13 National
Join Us, and Boston’s “Life Science Disruptors,” on Oct. 2 08/21/13 Boston
Epizyme Execs Share the Secret to a Successful IPO: PowerBars 08/15/13 Boston
East Coast Life Sciences Roundup: KiiLN, Celgene, Acceleron, & More 08/09/13 New York
Celgene Partner Acceleron Files For IPO; Plans to Raise Up to $75M 08/07/13 Boston
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Agios Prices Upsized IPO Above Range, Preps For Nasdaq Debut 07/24/13 Boston
The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts 07/22/13 National
East Coast Life Sciences Roundup: Celgene, Dunsire, Forma, & More 07/12/13 Boston
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
East Coast Life Sciences Roundup: IPO Madness, Amicus, & More 06/21/13 Boston
Bluebird Prices Ahead of Range, Takes Flight on Nasdaq Today 06/19/13 Boston
East Coast Life Sciences Roundup: ASCO, Follica, Aveo, & More 06/07/13 Boston
Third Rock Stocks Up With $516M New Fund, Looks to Start 16 Cos 03/25/13 Boston
East Coast Biotech Roundup: Moderna, bluebird, Blueprint 03/22/13 Boston
Page 1 of 2 next page »